Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder

Psychiatry Research
William CoryellBernard Carroll

Abstract

Convergent evidence indicates that HPA-axis hyperactivity is a risk factor for suicide in major depressive disorder, and seven independent reports have shown that patients with abnormal dexamethasone suppression test (DST) results have significantly higher rates of eventual suicide. The identification of interactions between DST results and other clinical predictors would enhance risk assessment, but modest sample sizes have limited such analyses in earlier cohorts. Subjects with major depressive disorder who participated in research protocols at the University of Michigan between 1980 and 1991, who had fully structured diagnostic interviews, and who underwent a 1-mg DST while actively depressed were screened with the National Death Index for a mean (S.D.) follow-up period of 18.0 (5.5) years. Of 334 subjects, 69 (20.7%) were identified as having died. Of these, 13 (18.8%) had died by suicide and 32 (46.4%) from cardiovascular causes. Baseline DST results did not significantly predict death from suicide or from cardiovascular disease for the sample as a whole. Significant relationships between DST results and later suicide did exist for inpatients, for patients with manifest suicidality and, in particular, for inpatients with m...Continue Reading

References

Jun 1, 1978·Archives of General Psychiatry·R L SpitzerE Robins
Feb 1, 1990·Acta Psychiatrica Scandinavica·W H NormanJ C Overholser
Feb 1, 1989·Biological Psychiatry·M AratóC B Nemeroff
Sep 1, 1987·The American Journal of Psychiatry·K Dorovini-Zis, A P Zis
Aug 1, 1981·The American Journal of Psychiatry·W Coryell, M A Schlesser
Sep 15, 1994·Biological Psychiatry·E SzigethyE D Caine
Apr 16, 1998·The American Journal of Forensic Medicine and Pathology·T DumserE Schubert
Jul 22, 1998·Archives of General Psychiatry·D L MusselmanC B Nemeroff
Aug 5, 2000·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·B WeberI Heuser
Dec 1, 2000·The American Journal of Psychiatry·J M Bostwick, V S Pankratz
May 1, 2001·The American Journal of Psychiatry·W Coryell, M Schlesser
Mar 4, 2003·The American Journal of Psychiatry·Meena VythilingamJ Craig Nelson
Nov 24, 2004·Journal of Affective Disorders·Boghos I YerevanianJim Mintz

❮ Previous
Next ❯

Citations

Jun 26, 2008·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Daniel LindqvistFredrik Vang
Sep 7, 2007·Annals of General Psychiatry·Xenia GondaZoltan Rihmer
Sep 2, 2009·Neuropsychiatric Disease and Treatment·Yogesh Dwivedi
Jul 31, 2012·Journal of Affective Disorders·Alexander McGirrGustavo Turecki
Jan 1, 2009·International Journal of Psychiatry in Clinical Practice·Feng XieKarina Hansen
Sep 14, 2007·Stress : the International Journal on the Biology of Stress·Irina Antonijevic
Aug 17, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Bun-Hee Lee, Yong-Ku Kim
Apr 20, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Lars DonathHolger H W Gabriel
Nov 12, 2015·Psychoneuroendocrinology·Daryl B O'ConnorRory C O'Connor
Dec 5, 2008·Journal of Affective Disorders·Jussi Jokinen, Peter Nordström
Sep 23, 2008·Psychoneuroendocrinology·Jussi Jokinen, Peter Nordström
Aug 2, 2008·Psychoneuroendocrinology·Daniel LindqvistLena Brundin
Apr 2, 2008·Psychoneuroendocrinology·William CoryellElizabeth Young
Jul 31, 2007·Journal of Affective Disorders·Jussi JokinenPeter Nordström
May 15, 2007·Journal of Affective Disorders·Jussi JokinenPeter Nordström
Feb 24, 2007·Psychiatry Research·Jussi JokinenPeter Nordström
Aug 30, 2006·Journal of Affective Disorders·Mehmet Yucel AgargunYavuz Selvi
Jan 1, 2014·TheScientificWorldJournal·Anna Leszczyńska-RodziewiczJoanna Hauser
Dec 15, 2010·Frontiers in Neuroendocrinology·Caitlin S WyrwollJonathan R Seckl
Jun 15, 2007·Expert Opinion on Pharmacotherapy·Roger S McIntyreJakub Z Konarski
Dec 14, 2011·Journal of Affective Disorders·Masoud KamaliMelvin G McInnis
Jul 28, 2007·Neuropsychobiology·Alicja Furgal-BorzychTadeusz Cichocki
Sep 14, 2016·Translational Psychiatry·B P ChangM K Nock
Nov 9, 2016·Psychiatry Research·Luciano Dias de Mattos SouzaKaren Jansen
Mar 18, 2017·The British Journal of Psychiatry : the Journal of Mental Science·Gregory CarterMatthew J Spittal
Jan 19, 2018·Neuropsychobiology·Ute LewitzkaLydia Günther
Oct 15, 2010·Journal of Psychopharmacology·Andrew J Bradley, Timothy G Dinan
Feb 23, 2010·European Archives of Psychiatry and Clinical Neuroscience·Maurizio PompiliDavid Lester
Mar 21, 2020·Frontiers in Psychiatry·Adrián Alacreu-CrespoPhilippe Courtet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.